Breaking News
FONT-SIZE Plus   Neg
Share SHARE

ArcelorMittal To Reduce Stake In Turkish Steelmaker Erdemir

RELATED NEWS
Trade MT now with 

Steel giant ArcelorMittal (MT: Quote) said Tuesday that it plans to sell up to half of its 25 percent stake in Turkey's biggest steelmaker Demir ve Çelik Fabrikalari T.A.S., or Erdemir. The sale is part of the company's efforts to focus on core assets and reduce its net debt.

Luxembourg-based ArcelorMittal plans to sell a package of 134.32 million shares and issue warrants in respect of another 134.32 million shares by way of a single accelerated bookbuilt offering to institutional investors. Goldman Sachs International (GS) is the sole bookrunner on the sale. ArcelorMittal currently owns 537.27 million shares in Erdemir, representing about 25 percent of Erdemir's share capital. The sale will reduce ArcelorMittal's stake in Erdemir to about 18.7 percent, and further to about 12.5 percent if all of the warrants are exercised.

The company said that investors will be offered an equal number of shares and warrants. For every three shares purchased, investors will receive one warrant each of Series A, B and C. The warrants will be transferable and freely tradable from the settlement date of the transaction.

Aditya Mittal, CFO and member of the Group Management Board for ArcelorMittal, said, "Erdemir is a strong business with excellent prospects. However, our stake has always been non-core as we have never exercised any control. So this decision is very much in line with our declared Group strategy of focusing on core assets and reducing net debt."

ArcelorMittal has agreed to a one-year lock up that prevents it from selling its remaining stake in Erdemir.

In early February, ArcelorMittal reported a wider loss for the fourth quarter, reflecting a large income tax expense recorded in the period. MT closed Tuesday's trading at $19.47, down $0.38 or 1.91 percent on a volume of 4.79 million shares.

Register
To receive FREE breaking news email alerts for Arcelor Mittal and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.